Resources
ANACAD Communique – November 2024
This document provides an update from the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) after their meeting in November 2024.
ANACAD Communique – September 2024
This document provides an update from the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) after their meeting in September 2024
ANACAD communique – June 2024
This document provides an update from the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) after their meeting in June 2024.
Joint Statement on IV Fluids – Health Ministers’ Meeting – 16 August 2024
Health Ministers met today in Sydney and discussed ongoing management of shortages of IV fluids.
![Cover page for the Alcohol & Other Drug Treatment Services – Grant guidelines [GO7025]](/sites/default/files/styles/h_thumbnail_max_width/public/2024-06/alcohol-and-other-drug-treatment-services-grant-guidelines-go7025.png?itok=4KF7jSvw)
15:31
Alcohol and Other Drug Treatment Services – Grant guidelines (GO7025)
This is a summary of key information about an Australian Government grant opportunity for the regions of Ceduna (SA), Bundaberg-Hervey Bay (Qld), East Kimberley and the Goldfields (WA).
ANACAD communique – February/March 2024
This document provides an update from the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) after their meeting on 29 February and 1 March 2024.
Australian secondary school students’ use of tobacco and e-cigarettes – 2022–2023
This report presents national secondary student use use of tobacco and e-cigarettes from the 2022–2023 Australian secondary school students tobacco and e-cigarettes survey.
Australian secondary school students’ use of alcohol and other substances – 2022–2023
This report presents national secondary student use of alcohol and other substances from the 2022–2023 Australian secondary school students alcohol and drug survey.
ANACAD communique – November 2023
This document provides an update from the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) after their meeting on 23 and 24 November 2023.
Australian Government response to public communications campaigns targeting drug and substance abuse
The Australian Government response to the Parliamentary Joint Committee on Law Enforcement Inquiry report on public communications campaigns targeting drug and substance abuse.
Naloxone purple postcard for healthcare providers
Promotional postcard containing important information and details for further reading regarding the Take Home Naloxone Program.
Naloxone pharmacy postcard
Postcard for pharmacists regarding the THN program. Includes information about how to appropriately discuss THN with patients.
Second variation for Naloxone available here sticker (pharmacy)
A sticker that healthcare providers can display to highlight the availability of Take Home Naloxone.
Naloxone available here clear sticker
A sticker that healthcare providers can display to highlight the availability of Take Home Naloxone.
Naloxone participation postcard
Promotional poster containing important information and details for further reading regarding the Take Home Naloxone Program.
Naloxone aqua pharmacy poster
Promotional poster containing important information and details for further reading regarding the Take Home Naloxone Program. Includes wording specific for pharmacy sites.
Naloxone purple poster
Promotional poster containing important information and details for further reading regarding the Take Home Naloxone Program.
ANACAD communique – August 2023
This document provides an update from the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) after their meeting on 29 and 30 August 2023.
Additional Alcohol and Other Drug Treatment Services funding – Consultation Outcomes
A summary of findings from consultations undertaken from April to June 2023. The report builds on a previous 2021 consultation to inform the Government’s approach to deliver additional alcohol and other drug treatment services across the four longest running former Cashless Debit Card trial sites.
Research and analysis plan – Evidence to support the HTA Review
This infographic provides a plan for the research and analysis that will inform the HTA Policy and Methods Review.
ANACAD communique – June 2023
This document provides an update from the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) after their meeting on 6 and 7 June 2023.
Alcohol and Other Drugs – National quality framework mapping standards refresh
The National Quality Framework for Drug and Alcohol Treatment Services sets a national quality benchmark which consumers can expect from alcohol and other drug treatment providers.
Consultation to Inform Funding for Alcohol and Other drug treatment services to support CDC trial participants
This report outlines the findings to inform the grant funding decision-making process for the delivery of alcohol and other drug treatment services for 4 Cashless Debit Card (CDC) trial sites: Ceduna (SA), Bundaberg-Hervey Bay (QLD), East Kimberley and the Goldfields (WA).
Health Technology Assessment Policy and Methods Review – Reference committee meeting agenda – 1 December 2022
Health Technology Assessment Policy and Methods Review Reference Committee agenda for the 1st meeting on 1 December 2022.
Health Technology Assessment Policy and Methods Review Reference Committee Communique – 27 January 2023 meeting
An update from the Health Technology Assessment Policy and Methods Review Reference Committee following its meeting on 27 January 2023.
Date last updated: